After the United Nations cast a large spotlight on the antimicrobial resistance crisis, the challenge now is turning recommendations into action. For drug makers, a key issue is getting government financial support for their investments in R&D.
"The engagement of government financing is going to be critical because we are talking numbers somewhere north of $20bn" to...





